Your browser doesn't support javascript.
loading
MCPIP1 reduces HBV-RNA by targeting its epsilon structure.
Li, Yingfang; Que, Lusheng; Fukano, Kento; Koura, Miki; Kitamura, Kouichi; Zheng, Xin; Kato, Takanobu; Aly, Hussein Hassan; Watashi, Koichi; Tsukuda, Senko; Aizaki, Hideki; Watanabe, Noriyuki; Sato, Yuko; Suzuki, Tadaki; Suzuki, Hiroshi I; Hosomichi, Kazuyoshi; Kurachi, Makoto; Wakae, Kousho; Muramatsu, Masamichi.
Afiliación
  • Li Y; Department of Molecular Genetics, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, 920-8640, Japan.
  • Que L; Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Fukano K; Department of Molecular Genetics, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, 920-8640, Japan.
  • Koura M; Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Kitamura K; Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Zheng X; Department of Molecular Genetics, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, 920-8640, Japan.
  • Kato T; Department of Molecular Genetics, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, 920-8640, Japan.
  • Aly HH; Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Watashi K; Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Tsukuda S; Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Aizaki H; Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Watanabe N; Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Sato Y; Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Suzuki T; Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Suzuki HI; Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Hosomichi K; Department of Pathology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Kurachi M; Department of Pathology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
  • Wakae K; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • Muramatsu M; Division of Molecular Oncology, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Sci Rep ; 10(1): 20763, 2020 11 27.
Article en En | MEDLINE | ID: mdl-33247161
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / Replicación Viral / ARN Viral / Virus de la Hepatitis B / Interleucina-1beta / Interacciones Huésped-Patógeno / Hepatitis B Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / Replicación Viral / ARN Viral / Virus de la Hepatitis B / Interleucina-1beta / Interacciones Huésped-Patógeno / Hepatitis B Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article